Literature DB >> 16449297

Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia.

Lauren Jacobson1, Tasneem Ansari, Jessica Potts, Owen P McGuinness.   

Abstract

Glucocorticoids have been implicated in hypoglycemia-induced autonomic failure but also contribute to normal counterregulation. To determine the influence of normal and hypoglycemia-induced levels of glucocorticoids on counterregulatory responses to acute and repeated hypoglycemia, we compared plasma catecholamines, corticosterone, glucagon, and glucose requirements in male wild-type (WT) and glucocorticoid-deficient, corticotropin-releasing hormone knockout (CRH KO) mice. Conscious, chronically cannulated, unrestrained WT and CRH KO mice underwent a euglycemic (Prior Eu) or hypoglycemic clamp (Prior Hypo) on day 1 followed by a hypoglycemic clamp on day 2 (blood glucose both days, 65 +/- 1 mg/dl). Baseline epinephrine and glucagon were similar, and norepinephrine was elevated, in CRH KO vs. WT mice. CRH KO corticosterone was almost undetectable (<1.5 microg/dl) and unresponsive to hypoglycemia. CRH KO glucose requirements were significantly higher during day 1 hypoglycemia despite epinephrine and glucagon responses that were comparable to or greater than those in WT. Hyperinsulinemic euglycemia did not increase hormones or glucose requirements above baseline. On day 2, Prior Hypo WT had significantly higher glucose requirements and significantly lower corticosterone and glucagon responses. Prior Hypo and Prior Eu CRH KO mice had similar day 2 glucose requirements. However, Prior Hypo CRH KO mice had significantly lower day 2 epinephrine and norepinephrine vs. Prior Eu CRH KO and tended to have lower glucagon than on day 1. We conclude that glucocorticoid insufficiency in CRH KO mice correlates with 1) impaired counterregulation during acute hypoglycemia and 2) complex effects after repeated hypoglycemia, neither preventing decreased hormone responses nor worsening glucose requirements.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449297      PMCID: PMC1762126          DOI: 10.1152/ajpendo.00526.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  45 in total

1.  Assessment of insulin secretion in the mouse.

Authors:  Marcela Brissova; Wendell E Nicholson; Masakazu Shiota; Alvin C Powers
Journal:  Methods Mol Med       Date:  2003

2.  PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat.

Authors:  S B Evans; C W Wilkinson; K Bentson; P Gronbeck; A Zavosh; D P Figlewicz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-11       Impact factor: 3.619

Review 3.  Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications.

Authors:  G A Bray
Journal:  Int J Obes Relat Metab Disord       Date:  2000-06

4.  Effects of antecedent hypoglycemia, hyperinsulinemia, and excess corticosterone on hypoglycemic counterregulation.

Authors:  K Shum; K Inouye; O Chan; J Mathoo; D Bilinski; S G Matthews; M Vranic
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-09       Impact factor: 4.310

Review 5.  The physiology of corticotropin-releasing hormone deficiency in mice.

Authors:  L J Muglia; L Jacobson; S C Weninger; K P Karalis; K Jeong; J A Majzoub
Journal:  Peptides       Date:  2001-05       Impact factor: 3.750

6.  Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia.

Authors:  Daniel E Flanagan; Tara Keshavarz; Mark L Evans; Sally Flanagan; Xiaoning Fan; Ralph J Jacob; Robert S Sherwin
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

7.  Prevention of overt hypoglycemia during exercise: stimulation of endogenous glucose production independent of hepatic catecholamine action and changes in pancreatic hormone concentration.

Authors:  Robert H Coker; Yoshiharu Koyama; Joshua C Denny; Raul C Camacho; D Brooks Lacy; David H Wasserman
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

8.  Cortisol elevations comparable to those that occur during hypoglycemia do not cause hypoglycemia-associated autonomic failure.

Authors:  Bharathi Raju; Veronica P McGregor; Philip E Cryer
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

Review 9.  Hypoglycemia in diabetes.

Authors:  Philip E Cryer; Stephen N Davis; Harry Shamoon
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

Review 10.  Stress and diabetes mellitus.

Authors:  R S Surwit; M S Schneider; M N Feinglos
Journal:  Diabetes Care       Date:  1992-10       Impact factor: 19.112

View more
  10 in total

1.  Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice.

Authors:  Julio E Ayala; Varman T Samuel; Gregory J Morton; Silvana Obici; Colleen M Croniger; Gerald I Shulman; David H Wasserman; Owen P McGuinness
Journal:  Dis Model Mech       Date:  2010-08-16       Impact factor: 5.758

2.  Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice.

Authors:  Lauren Jacobson; Tasneem Ansari; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-04       Impact factor: 4.310

Review 3.  NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse.

Authors:  Owen P McGuinness; Julio E Ayala; Maren R Laughlin; David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-28       Impact factor: 4.310

4.  Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis.

Authors:  G J Taborsky; Q Mei; D J Hackney; D P Figlewicz; R LeBoeuf; T O Mundinger
Journal:  Diabetologia       Date:  2009-10-02       Impact factor: 10.122

Review 5.  Approach to assessing determinants of glucose homeostasis in the conscious mouse.

Authors:  Curtis C Hughey; David H Wasserman; Robert S Lee-Young; Louise Lantier
Journal:  Mamm Genome       Date:  2014-07-30       Impact factor: 2.957

6.  Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure.

Authors:  Michal M Poplawski; Jason W Mastaitis; Charles V Mobbs
Journal:  Diabetes       Date:  2010-09-01       Impact factor: 9.461

7.  Glucocorticoid signaling in the arcuate nucleus modulates hepatic insulin sensitivity.

Authors:  Chun-Xia Yi; Ewout Foppen; William Abplanalp; Yuanqing Gao; Anneke Alkemade; Susanne E la Fleur; Mireille J Serlie; Eric Fliers; Ruud M Buijs; Matthias H Tschöp; Andries Kalsbeek
Journal:  Diabetes       Date:  2011-12-30       Impact factor: 9.461

8.  Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice.

Authors:  Julio E Ayala; Deanna P Bracy; Carlo Malabanan; Freyja D James; Tasneem Ansari; Patrick T Fueger; Owen P McGuinness; David H Wasserman
Journal:  J Vis Exp       Date:  2011-11-16       Impact factor: 1.355

9.  Effects of Growth Hormone Receptor Ablation in Corticotropin-Releasing Hormone Cells.

Authors:  Willian O Dos Santos; Daniela O Gusmao; Frederick Wasinski; Edward O List; John J Kopchick; Jose Donato
Journal:  Int J Mol Sci       Date:  2021-09-14       Impact factor: 5.923

10.  Glucose metabolism in vivo in four commonly used inbred mouse strains.

Authors:  Eric D Berglund; Candice Y Li; Greg Poffenberger; Julio E Ayala; Patrick T Fueger; Shannon E Willis; Marybeth M Jewell; Alvin C Powers; David H Wasserman
Journal:  Diabetes       Date:  2008-04-08       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.